The Medicines Company EBITDA Margin 2010-2019 | MDCO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for The Medicines Company (MDCO) over the last 10 years. The current EBITDA margin for The Medicines Company as of September 30, 2019 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2018-09-30 |
$0.02B |
$-0.29B |
-1825.00% |
2018-06-30 |
$0.03B |
$-0.30B |
-1118.52% |
2018-03-31 |
$0.04B |
$-0.63B |
-1747.22% |
2017-12-31 |
$0.05B |
$-0.62B |
-1368.89% |
2017-09-30 |
$0.05B |
$-0.52B |
-986.79% |
2017-06-30 |
$0.08B |
$-0.53B |
-642.17% |
2017-03-31 |
$0.13B |
$-0.24B |
-188.98% |
2016-12-31 |
$0.16B |
$-0.26B |
-165.00% |
2016-09-30 |
$0.20B |
$-0.18B |
-91.33% |
2016-06-30 |
$0.22B |
$-0.21B |
-97.21% |
2016-03-31 |
$0.24B |
$-0.19B |
-82.13% |
2015-12-31 |
$0.30B |
$-0.13B |
-42.71% |
2015-09-30 |
$0.37B |
$-0.14B |
-38.59% |
2015-06-30 |
$0.48B |
$-0.05B |
-10.77% |
2015-03-31 |
$0.59B |
$-0.01B |
-1.52% |
2014-12-31 |
$0.66B |
$0.02B |
2.73% |
2014-09-30 |
$0.66B |
$0.01B |
1.98% |
2014-06-30 |
$0.66B |
$0.05B |
7.15% |
2014-03-31 |
$0.65B |
$0.11B |
16.41% |
2013-12-31 |
$0.63B |
$0.07B |
10.56% |
2013-09-30 |
$0.66B |
$0.10B |
14.95% |
2013-06-30 |
$0.63B |
$0.09B |
13.76% |
2013-03-31 |
$0.59B |
$0.07B |
11.73% |
2012-12-31 |
$0.56B |
$0.10B |
17.35% |
2012-09-30 |
$0.53B |
$0.08B |
14.66% |
2012-06-30 |
$0.52B |
$0.07B |
13.37% |
2012-03-31 |
$0.50B |
$0.06B |
12.60% |
2011-12-31 |
$0.49B |
$0.07B |
13.61% |
2011-09-30 |
$0.47B |
$0.06B |
13.11% |
2011-06-30 |
$0.46B |
$0.08B |
16.38% |
2011-03-31 |
$0.45B |
$0.08B |
17.41% |
2010-12-31 |
$0.44B |
$0.07B |
16.89% |
2010-09-30 |
$0.42B |
$0.03B |
7.86% |
2010-06-30 |
$0.41B |
$0.01B |
2.91% |
2010-03-31 |
$0.41B |
$0.00B |
0.25% |
2009-12-31 |
$0.40B |
$-0.02B |
-4.21% |